Beclomethasone Dipropionate Aerosol, Metered
Product Images NDC 69238-1290

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 13 technical images submitted to the FDA as part of the official labeling for Beclomethasone Dipropionate (NDC 69238-1290). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Amneal Pharmaceuticals Ny Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structural Formula (Beclomethasone Dipropionate Hfa Inhalation Aerosol 1)

Structural Formula (Beclomethasone Dipropionate Hfa Inhalation Aerosol 1)
Chemical structure diagram of Beclomethasone Dipropionate showing its molecular framework with labeled functional groups, including ester and hydroxyl groups.*
FDA Label Image

40 Mcg Label (Beclomethasone Dipropionate Hfa Inhalation Aerosol 10)

40 Mcg Label (Beclomethasone Dipropionate Hfa Inhalation Aerosol 10)
Beclomethasone Dipropionate HFA 40 mcg Inhalation Aerosol label displaying the product as an oral inhalation with Amneal Actuator only. The package contains 120 metered inhalations with 8.7 g net contents. Distributed by Amneal Pharmaceuticals LLC, made in Ireland, with storage instructions and a barcode visible.*
FDA Label Image

40 Mcg Ifc (Beclomethasone Dipropionate Hfa Inhalation Aerosol 11)

40 Mcg Ifc (Beclomethasone Dipropionate Hfa Inhalation Aerosol 11)
Packaging label for Beclomethasone Dipropionate HFA Inhalation Aerosol 40 mcg by Amneal Pharmaceuticals NY LLC. The label states it is for oral inhalation with Amneal actuator only, includes a dose counter, and contains 120 metered inhalations. Net contents are 8.7 grams. The label also includes warnings, storage instructions, and distributor information.*
FDA Label Image

80 Mcg Label (Beclomethasone Dipropionate Hfa Inhalation Aerosol 12)

80 Mcg Label (Beclomethasone Dipropionate Hfa Inhalation Aerosol 12)
Label for Beclomethasone Dipropionate HFA inhalation aerosol, 80 mcg strength. The label indicates it is for oral inhalation with Amneal Actuator only, containing 120 metered inhalations, net content 8.7 g. Distributed by Amneal Pharmaceuticals LLC, Bridgewater, NJ.*
FDA Label Image

80 Mcg Ifc (Beclomethasone Dipropionate Hfa Inhalation Aerosol 13)

80 Mcg Ifc (Beclomethasone Dipropionate Hfa Inhalation Aerosol 13)
Packaging label for Beclomethasone Dipropionate HFA Inhalation Aerosol, 80 mcg strength, metered aerosol for respiratory inhalation. The label indicates 120 metered inhalations per container, for oral inhalation with Amneal actuator only, with dose counter, and distributed by Amneal Pharmaceuticals NY LLC. The label includes warnings, storage instructions, and dosage administration notes.*
FDA Label Image

Figure 1 (Beclomethasone Dipropionate Hfa Inhalation Aerosol 2)

Figure 1 (Beclomethasone Dipropionate Hfa Inhalation Aerosol 2)
A line graph comparing mean changes in AM PEF (L/min) over weeks 1 to 5 for three treatments: Beclomethasone dipropionate HFA 40 mcg twice daily, Beclomethasone dipropionate HFA 80 mcg twice daily, and HFA-134a placebo. The graph shows values increasing over time for the two active treatments and remaining flat or decreasing for the placebo.*
FDA Label Image

Figure 2 (Beclomethasone Dipropionate Hfa Inhalation Aerosol 3)

Figure 2 (Beclomethasone Dipropionate Hfa Inhalation Aerosol 3)
This line graph depicts mean AM peak expiratory flow (PEF) rates in L/min over a 12-week period. It compares three treatments: Beclomethasone dipropionate HFA 160 mcg twice daily, CFC-BDP 336 mcg twice daily, and HFA 134a placebo, with data points during run-in, oral steroid treatment, and weeks 1-12 of study.*
FDA Label Image

Figure 3 (Beclomethasone Dipropionate Hfa Inhalation Aerosol 4)

Figure 3 (Beclomethasone Dipropionate Hfa Inhalation Aerosol 4)
A line chart showing mean change in FEV1 as a percentage of predicted values over six weeks. It compares different treatments including Beclomethasone Dipropionate HFA at 40 mcg, 160 mcg, and 320 mcg twice daily, as well as CFC-BDP and CFC-BDP at various dosages twice daily. The x-axis represents weeks 1 to 6, and the y-axis shows mean change in FEV1 percentage, illustrating treatment response over time.*
FDA Label Image

Figure A (Beclomethasone Dipropionate Hfa Inhalation Aerosol 5)

Figure A (Beclomethasone Dipropionate Hfa Inhalation Aerosol 5)
An instructional diagram showing the components of a metered-dose inhaler device. It labels the metal canister, plastic actuator, mouthpiece, and cap, illustrating their arrangement and how they fit together for use.*
FDA Label Image

Figure B (Beclomethasone Dipropionate Hfa Inhalation Aerosol 6)

Figure B (Beclomethasone Dipropionate Hfa Inhalation Aerosol 6)
Illustration showing the dose counter feature on a Beclomethasone Dipropionate aerosol inhaler. The image highlights the location of the dose counter indicating the remaining number of doses, here showing 120.*
FDA Label Image

Figure C (Beclomethasone Dipropionate Hfa Inhalation Aerosol 7)

Figure C (Beclomethasone Dipropionate Hfa Inhalation Aerosol 7)
An instructional illustration showing a hand holding a beclomethasone dipropionate metered-dose inhaler with labeled parts including the mouthpiece and cap. The image demonstrates removing the cap from the mouthpiece prior to use.*
FDA Label Image

Figure D (Beclomethasone Dipropionate Hfa Inhalation Aerosol 8)

Figure D (Beclomethasone Dipropionate Hfa Inhalation Aerosol 8)
An illustration showing a respiratory inhaler with a focus on its dose counter display, which reads '122'. The image highlights the location and appearance of the dose counter on the Beclomethasone Dipropionate aerosol inhaler.*
FDA Label Image

Figure E (Beclomethasone Dipropionate Hfa Inhalation Aerosol 9)

Figure E (Beclomethasone Dipropionate Hfa Inhalation Aerosol 9)
An instructional illustration showing proper use of a metered dose inhaler for respiratory delivery. The image depicts a person holding the inhaler upright with one hand, pressing the canister down with an arrow indicating the direction of pressure, while placing the mouthpiece in their mouth to inhale the medication.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.